All In Biotech

Free tool

FAERS Monitor: Yutrepia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213005 or its brand name (Yutrepia, Treprostinil Sodium). Reports on generic versions are filed under their own applications.

Reports

10,115

Serious

6,803

67% of reports

Hospitalization

4,556

Death reported

1,369

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea2,186
  • headache2,024
  • cough1,793
  • diarrhoea1,558
  • nausea1,323
  • dizziness1,227
  • fatigue1,199
  • hypotension812
  • death744
  • oxygen saturation decreased692
  • vomiting646
  • malaise559
  • dyspnoea exertional539
  • pain in extremity525
  • pneumonia504

Reports by year received

View as table
YearReports
20051
20063
20071
20082
20098
201013
201122
201240
201342
201471
2015146
201690
2017103
2018101
2019456
2020481
2021623
2022865
20231,150
20241,046
20251,754
20263,097

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,044 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dyspnoea exertionalSignal53930.227.814,984
oxygen saturation decreasedSignal69225.924.116,388
coughSignal1,79313.412.820,659
hypotensionSignal8128.47.95,354
dyspnoeaSignal2,1868.17.813,825
headacheSignal2,0246.76.510,142
dizzinessSignal1,2275.14.94,159
diarrhoeaSignal1,5585.04.85,171
pain in extremitySignal5253.73.41,049
nauseaSignal1,3233.53.32,423
pneumoniaSignal5043.23.0789
fatigueSignal1,1993.23.01,884
vomitingSignal6462.92.7796
malaiseSignal5592.72.4585
death7441.81.7273

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.